EMAIL THIS PAGE TO A FRIEND

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Intestinal deletion of leptin signaling alters activity of nutrient transporters and delayed the onset of obesity in mice.


PMID 24928195

Abstract

The importance of B-isoform of leptin receptor (LEPR-B) signaling in the hypothalamus, pancreas, or liver has been well characterized, but in the intestine, a unique site of entry for dietary nutrition into the body, it has been relatively ignored. To address this question, we characterized a mouse model deficient for LEPR-B specifically in intestinal epithelial cells (IECs). (IEC)LEPR-B-knockout (KO) and wild-type (WT) mice were generated by Cre-Lox strategy and fed a normal or high-fat diet (HFD). The analyses of the animals involved histology and immunohistochemistry of intestinal mucosa, indirect calorimetric measurements, whole-body composition, and expression and activities of nutrient transporters. (IEC)LEPR-B-KO mice exhibited a 2-fold increase in length of jejunal villi and have normal growth on a normal diet but were less susceptible (P<0.01) to HFD-induced obesity. No differences occurred in energy intake and expenditure between (IEC)LEPR-B-WT and -KO mice, but (IEC)LEPR-B-KO mice fed an HFD showed increased excreted fats (P<0.05). Activities of the Na(+)/glucose cotransporter SGLT-1 and GLUT2 were unaffected in LEPR-B-KO jejunum, while GLUT5-mediated fructose transport and PepT1-mediated peptide transport were substantially reduced (P<0.01). These data demonstrate that intestinal LEPR-B signaling is important for the onset of diet-induced obesity. They suggest that intestinal LEPR-B could be a potential per os target for prevention against obesity.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA030899
Anti-LEPR antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2500591
Anti-Leptin Receptor antibody produced in goat, affinity isolated antibody, buffered aqueous solution
L9536 Anti-Leptin Receptor antibody produced in goat, affinity isolated antibody, lyophilized powder
AV41706
Anti-SLC2A2 antibody produced in rabbit, affinity isolated antibody
HPA028997
Anti-SLC2A2 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1409671
Anti-SLC2A5 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA005449
Anti-SLC2A5 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV42096
Anti-SLC2A5 antibody produced in rabbit, affinity isolated antibody
F0127
D-(−)-Fructose, ≥99%
C6H12O6
F2543
D-(−)-Fructose, BioXtra
C6H12O6
F3510
D-(−)-Fructose, BioReagent, suitable for cell culture, suitable for insect cell culture
C6H12O6
F9048
D-(−)-Fructose, meets USP testing specifications
C6H12O6
F2793
D-(−)-Fructose, analytical standard, analytical standard for fructose assay kit, for use with enzymatic assay kit FA20
C6H12O6
47739
D-(−)-Fructose, BioUltra, ≥99.0% (HPLC)
C6H12O6
47740
D-(−)-Fructose, for microbiology, ≥99.0%
C6H12O6
47748
D-(−)-Fructose, tested according to Ph.Eur.
C6H12O6
1286504
Fructose, United States Pharmacopeia (USP) Reference Standard
C6H12O6
F0550000
Fructose, European Pharmacopoeia (EP) Reference Standard
C6H12O6
PHR1002
Fructose, Pharmaceutical Secondary Standard; Certified Reference Material
C6H12O6
SAB1402837
Monoclonal Anti-LEPR antibody produced in mouse, clone 2H5, purified immunoglobulin, buffered aqueous solution
SAB4100072
Monoclonal Anti-SLC2A5 antibody produced in mouse, clone SLC2A5-C53, culture supernatant
SAB4100055
Monoclonal Anti-SLC2A5 antibody produced in mouse, clone SLC2A5-A53, culture supernatant